FDA provides pivotal agreement on EB613 Phase 3 design, confirming Bone Mineral Density (BMD) as primary endpoint and ...

Orforglipron, the new weight loss pill manufactured by Eli Lilly, helped patients in a recent study lose a significant amount of weight, the company said.

Palantir Technologies • PLTR-Nasdaq Hold • $160.66 on Aug. 4 by Deutsche Bank Palantir delivered another impressive result, ...